Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 27, 20 December 2023
* Author to whom correspondence should be addressed.
Prostate-Specific antigen (PSA) is one of the most popular biomarkers for prostate carcinoma (PCA) at present. PSA indicates initial cancer and recurrence following therapy, but does not distinguish clearly from local or remote lesions. Molecular and functional scans, which can give a thorough and complete picture of PCR amplification, are a more robust instrument for detecting and assessing the progression of cancer at the stage as well as at subsequent stages. In this paper, PET or CT, MRI are useful for diagnosing, staging and regrading of PCA, as well as their application to prognostic, therapeutic and therapeutic evaluation. Novel imaging techniques, including novel radiotracers and PET/MRI, are also presented in this paper. Looking forward, the evolution of imaging techniques holds promise for improved PCA management. Continued innovation in radiotracers and hybrid imaging technologies such as PET/MRI could revolutionize early detection, accurate staging, and effective treatment, paving the way for precision oncology in prostate cancer.
CT, MRI, PSA, PCA
1. Daryanani A, and Baris T 2022 WB Saunders 52(3) 365-373
2. Kuhn F P, Hüllner M, Mader C E 2014 Journal of nuclear medicine 55(4) 551-558
3. Tsim S, Cowell G W K A Lung Cancer 2020 150 12-20.
4. Vaman D and Prasad R 2013 International Journal of Latest Trends in Engineering and Technology (IJITET) 3 1
5. Sharma D and Jindal G 2011 International Conference on Computational Techniques and Artificial Intelligence (ICCTAI'2011) 17 872-880
6. Ada and Kaur R 2013 International Journal of Application or Innovation in Engineering and Management (IJAIEM) 2 385-383
7. Vaman D and Prasad R 2013 International Journal of Latest Trends in Engineering and Technology (IJLTET) 3 372-378
8. Gupta B and Tiwari S 2014 International Journal of Computer Applications 86 15-17
9. Sohn K M, Lee J M, Lee S Y 2000 American journal of roentgenology 174(6) 1551-1557
10. Litmanovich D, Bankier A A, Cantin L 2009 American Journal of Roentgenology 193(4) 928-940
11. Hsieh J, Nett B, Yu Z 2013 Current Radiology Reports 1 39-51.
12. Genant H K, Engelke K, Prevrhal S 2008 Rheumatology 47(4) iv9-iv16.
13. Klopfenstein B J, Kim M S, Krisky C M 2012 The British journal of radiology 85(1018) e826-e830.
14. Daryanani A, Turkbey B 2022 WB Saunders 52(3) 365-373.
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).